English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
生物通
2 天
靶向 EZH2:杜氏肌营养不良症治疗新曙光
目前,虽然基因编辑疗法为 DMD 的治疗带来了一丝希望,但临床应用的道路上仍布满荆棘,比如难以确定临床疗效、无法有效控制潜在的脱靶效应等。而糖皮质激素(如地夫可特、泼尼松)虽能延缓疾病进展,却也伴随着肥胖、行为改变、身材矮小和骨质减少等诸多副作用,就像 “饮鸩止渴”,让患者陷入两难境地。因此,寻找更安全有效的治疗方法,成为了医学领域亟待攻克的难题。
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
今日热点
Return to Earth
Agrees to limited ceasefire
Delta plane wing hits runway
Halts care for trans veterans
Texas measles cases rise
Morgan says he’s OK
Free checked bag promotion
Trump revokes protection
Bryan Bedford to lead FAA
Worker stole $1.6 million
US housing starts rebound
Corruption trial begins
To open headquarters in TX
Siemens to cut jobs
Judge on USAID shutdown
Patient dies post-therapy
Honduras plane crash
Fire danger continues for OK
Tapped as top bank cop
Lebanon-Syria ceasefire
WH says US won't return
Reinstating fired workers
Plea to halt execution denied
DOGE gains access to USIP?
ISR conducts strikes in Gaza
JFK files to be released
Removing privacy setting
Peru declares emergency
Parents on missing daughter
'Sunrise on the Reaping'
Drops gun violence advisory
On judicial impeachment call
'Get Together' singer dies
反馈